Market revenue in 2022 | USD 766.5 million |
Market revenue in 2030 | USD 1,402.3 million |
Growth rate | 7.8% (CAGR from 2022 to 2030) |
Largest segment | Osteoarthritis |
Fastest growing segment | Dermal Fillers |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Osteoarthritis was the largest segment with a revenue share of 72.58% in 2022. Horizon Databook has segmented the Japan hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Rising awareness among Japanese population regarding the benefits of hyaluronic acid on skin and treatment of various diseases is boosting market growth in Japan. The influence of social media and selfies is increasing in the young generation.
They desire picture-perfect celebrity looks. This is leading to increased adoption of cosmetic procedures in the country. Hyaluronic acid dermal fillers remained the third most common nonsurgical procedure in Japan in 2020, according to ISAPS.
In 2020, 273,821 facial injectable procedures were performed; out of which, 66,712 were performed using hyaluronic acid. In Japan, the government has mandated osteoporosis screening. This is increasing healthconsciousness among the population.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into Japan hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account